Defence Therapeutics Inc.
DTC
株式のランク
#29781
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
株価
$0.24953854
最終同期: 2026-10-16
時価総額
$18.91M
変化（1日）
-5.56%
変化（1年）
-53.23%
国
CA
取引 Defence Therapeutics Inc. (DTC)
カテゴリー
Healthcare
の時価総額 Defence Therapeutics Inc.(DTC)
時価総額: $18.91M
October 2026時点で、Defence Therapeutics Inc. の時価総額は $18.91M です。これは、当社のデータによると、Defence Therapeutics Inc. が世界で29781st番目に価値のある企業であることを意味します。時価総額は、上場企業の発行済株式の総市場価値であり、企業の価値を測るためによく使用されます。
Defence Therapeutics Inc. の時価総額の履歴（2021 から 2026 まで）
